186 related articles for article (PubMed ID: 19595180)
1. [Screening and identification analysis of serum protein biomarkers in nephroblastoma].
Wang JX; Yang SB; Liu QL; Dong R; Fan YX; Zhang Q; Yang FQ; Wu P; Yu JK; Zheng S
Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1259-63. PubMed ID: 19595180
[TBL] [Abstract][Full Text] [Related]
2. [Detecting biomarkers from serum in nephroblastoma patients with support vector machine].
Wang JX; Zhang J; Liu QL; Wang L; Fan YZ; Yu JK; Zheng S
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2982-5. PubMed ID: 17288811
[TBL] [Abstract][Full Text] [Related]
3. [Detection and identification of specific serum biomarkers in papillary thyroid cancer].
Wang JX; Dong R; Liu QL; Yang SB; Fan YX; Zhang Q; Yang FQ; Wu P; Yu JK; Zheng S
Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):265-8. PubMed ID: 19615280
[TBL] [Abstract][Full Text] [Related]
4. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.
Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P
Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929
[TBL] [Abstract][Full Text] [Related]
5. Identification of serum biomarkers for pancreatic adenocarcinoma by proteomic analysis.
Guo J; Wang W; Liao P; Lou W; Ji Y; Zhang C; Wu J; Zhang S
Cancer Sci; 2009 Dec; 100(12):2292-301. PubMed ID: 19775290
[TBL] [Abstract][Full Text] [Related]
6. [Surface enhanced laser desorption/ionization time-of-flight mass spectrometry profiling of serum in detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis].
Cheng L; Zhou L; Tao L; Zhang M; Cui JF; Liu YK
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2526-30. PubMed ID: 18067823
[TBL] [Abstract][Full Text] [Related]
7. Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer.
Kong F; Nicole White C; Xiao X; Feng Y; Xu C; He D; Zhang Z; Yu Y
Gynecol Oncol; 2006 Feb; 100(2):247-53. PubMed ID: 16229881
[TBL] [Abstract][Full Text] [Related]
8. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis.
Wei YS; Zheng YH; Liang WB; Zhang JZ; Yang ZH; Lv ML; Jia J; Zhang L
Cancer; 2008 Feb; 112(3):544-51. PubMed ID: 18085639
[TBL] [Abstract][Full Text] [Related]
9. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
[TBL] [Abstract][Full Text] [Related]
10. Potential biomarkers for diagnosis of sarcoidosis using proteomics in serum.
Bons JA; Drent M; Bouwman FG; Mariman EC; van Dieijen-Visser MP; Wodzig WK
Respir Med; 2007 Aug; 101(8):1687-95. PubMed ID: 17446058
[TBL] [Abstract][Full Text] [Related]
11. [Serum proteomic patterns may assist the diagnosis of solitary pulmonary nodules].
Luo XY; Chen HQ; Sun YH; Zhou JH; Wang WF; Liao P; Xiang CQ
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):907-10. PubMed ID: 17533741
[TBL] [Abstract][Full Text] [Related]
12. Application of SELDI-TOF-MS to identify serum biomarkers for renal cell carcinoma.
Xu G; Xiang CQ; Lu Y; Kang XN; Liao P; Ding Q; Zhang YF
Cancer Lett; 2009 Sep; 282(2):205-13. PubMed ID: 19362769
[TBL] [Abstract][Full Text] [Related]
13. [Preoperative molecular staging of colorectal cancers by CM10 ProteinChip and SELDI-TOF-MS analysis].
Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):753-7. PubMed ID: 17366787
[TBL] [Abstract][Full Text] [Related]
14. [Serum proteomics profiling for diagnosis of myasthenia gravis].
Wu GY; Pang JZ; Cheng C; Lu JJ; Ma J; Gu Y; Zhong FT; Luo HH
Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(31):2184-7. PubMed ID: 20058595
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel serum biomarkers in child nephroblastoma using proteomics technology.
Zhang Q; Wang J; Dong R; Yang S; Zheng S
Mol Biol Rep; 2011 Jan; 38(1):631-8. PubMed ID: 20369385
[TBL] [Abstract][Full Text] [Related]
16. [Application of liquid chip-mass spectrometry technology for screening serum biomarker proteins in lung squamous cell carcinoma].
Bu LN; Yang SY; Du J; Nan YD; Lin XL; Zheng HD; Huo SF; Shang WL; Liu YF
Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(24):1662-6. PubMed ID: 19957521
[TBL] [Abstract][Full Text] [Related]
17. Targeted serum glycoproteomics for the discovery of lung cancer-associated glycosylation disorders using lectin-coupled ProteinChip arrays.
Ueda K; Fukase Y; Katagiri T; Ishikawa N; Irie S; Sato TA; Ito H; Nakayama H; Miyagi Y; Tsuchiya E; Kohno N; Shiwa M; Nakamura Y; Daigo Y
Proteomics; 2009 Apr; 9(8):2182-92. PubMed ID: 19322776
[TBL] [Abstract][Full Text] [Related]
18. Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling.
Findeisen P; Zapatka M; Peccerella T; Matzk H; Neumaier M; Schadendorf D; Ugurel S
J Clin Oncol; 2009 May; 27(13):2199-208. PubMed ID: 19307507
[TBL] [Abstract][Full Text] [Related]
19. Identification of hemoglobin-alpha and -beta subunits as potential serum biomarkers for the diagnosis and prognosis of ovarian cancer.
Woong-Shick A; Sung-Pil P; Su-Mi B; Joon-Mo L; Sung-Eun N; Gye-Hyun N; Young-Lae C; Ho-Sun C; Heung-Jae J; Chong-Kook K; Young-Wan K; Byoung-Don H; Hyun-Sun J
Cancer Sci; 2005 Mar; 96(3):197-201. PubMed ID: 15771624
[TBL] [Abstract][Full Text] [Related]
20. Proteomic identification of serum biomarkers for head and neck cancer surveillance.
Gourin CG; Zhi W; Adam BL
Laryngoscope; 2009 Jul; 119(7):1291-302. PubMed ID: 19444892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
